World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
59858
World Ranking
2954
National Ranking
158

Matthias Schwab publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Matthias Schwab sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 716 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Matthias Schwab D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Matthias Schwab sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2014 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Physiology and Pharmacology/Toxicology
  • 1994 - Member of Academia Europaea

Overview

Matthias Schwab is affiliated with the University of Tübingen in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on subfields including Oncology, Molecular Biology, Pharmacology, Pediatrics, Perinatology and Child Health, and Genetics.

The main topics covered in Schwab's scientific work include:

  • Pharmacogenetics and Drug Metabolism
  • Drug Transport and Resistance Mechanisms
  • Pharmaceutical Studies and Practices
  • Estrogen and Related Hormone Effects
  • Cancer Genomics and Diagnostics
  • Renal Cell Carcinoma Treatment
  • Multiple Sclerosis Research Studies

Frequent coauthors collaborating with Schwab are:

  • Elke Schaeffeler (61 collaborations)
  • Ute Hofmann (31 collaborations)
  • Thomas E. Mürdter (30 collaborations)
  • Stefan Winter (29 collaborations)
  • Roman Tremmel (25 collaborations)

Common publication venues for Schwab's work include:

  • Clinical Pharmacology & Therapeutics (16 publications)
  • Cancer Research (8 publications)
  • CPT Pharmacometrics & Systems Pharmacology (7 publications)
  • Pharmaceutics (7 publications)
  • Cells (7 publications)

Recent papers by Matthias Schwab include:

  • "A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study" (2023, The Lancet)
  • "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing" (2020, Clinical Pharmacology & Therapeutics)
  • "The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets" (2021, Cancer Discovery)
  • "Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial" (2022, The Lancet Infectious Diseases)
  • "Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy" (2020, Genome Medicine)

The scientist has also contributed to book publications with Springer Science+Business Media, including:

  • "Pediatric Pharmacotherapy" (2020)
  • "Precision Medicine" (2023)

Matthias Schwab's research is connected to awards such as membership in the German National Academy of Sciences Leopoldina since 2014, with a focus on Physiology and Pharmacology/Toxicology, and membership in Academia Europaea since 1994.

Best Publications

  • Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

    Ulrich M. Zanger;Matthias Schwab;Matthias Schwab

  • Metformin improves healthspan and lifespan in mice

    Alejandro Martin-Montalvo;Evi M. Mercken;Sarah J. Mitchell;Sarah J. Mitchell;Sarah J. Mitchell;Hector H. Palacios

  • Reduced Paneth cell α-defensins in ileal Crohn's disease

    Jan Wehkamp;Nita H. Salzman;Edith Porter;Edith Porter;Sabine Nuding

  • NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.

    J. Wehkamp;J. Harder;M. Weichenthal;M. Schwab

  • Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

    Ingolf Cascorbi;Thomas Gerloff;Andreas Johne;Christian Meisel

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

    M V Relling;E E Gardner;W J Sandborn;K Schmiegelow

  • A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

    Martin Filipits;Margaretha Rudas;Raimund Jakesz;Peter Dubsky

  • Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

    Ulrich M. Zanger;Ulrich M. Zanger;Miia Turpeinen;Miia Turpeinen;Miia Turpeinen;Kathrin Klein;Kathrin Klein;Matthias Schwab;Matthias Schwab

  • A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon.

    Klaus Fellermann;Daniel E. Stange;Elke Schaeffeler;Hartmut Schmalzl

  • Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.

    Thomas Lang;Kathrin Klein;Joachim Fischer;Andreas K. Nüssler

  • Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

    Werner Schroth;Matthew P. Goetz;Ute Hamann;Peter A. Fasching;Peter A. Fasching

  • Sex is a major determinant of CYP3A4 expression in human liver

    Renzo Wolbold;Kathrin Klein;Oliver Burk;Andreas K. Nüssler

  • Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.

    Werner Schroth;Lydia Antoniadou;Peter Fritz;Matthias Schwab

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

    Ursula Amstutz;Linda M. Henricks;Steven M. Offer;Julia Barbarino

  • Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

    Mary V. Relling;Matthias Schwab;Matthias Schwab;Michelle Whirl-Carrillo;Guilherme Suarez-Kurtz

  • Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants

    Elke Schaeffeler;Christine Fischer;Dierk Brockmeier;Dorothee Wernet

  • High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).

    Mikko Niemi;Elke Schaeffeler;Thomas Lang;Martin F Fromm

  • The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.

    Monika Hitzl;Siegfried Drescher;Heiko Van Der Kuip;Elke Schäffeler

  • Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

    Matthias Schwab;Ulrich M. Zanger;Claudia Marx;Elke Schaeffeler

  • NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

    Takaya Moriyama;Takaya Moriyama;Rina Nishii;Rina Nishii;Virginia Perez-Andreu;Wenjian Yang

Frequent Co-Authors

Michel Eichelbaum
Michel Eichelbaum University of Tübingen
Ute Hofmann
Ute Hofmann University of Tübingen
Ulrich M. Zanger
Ulrich M. Zanger Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Kathrin Klein
Kathrin Klein Robert Bosch (Germany)
Eduard F. Stange
Eduard F. Stange Robert Bosch Hospital
Jan Wehkamp
Jan Wehkamp University of Tübingen
Otto W. Witte
Otto W. Witte Friedrich Schiller University Jena
Meinrad Gawaz
Meinrad Gawaz University of Tübingen
Ulrich Klotz
Ulrich Klotz Robert Bosch (Germany)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore studying Medicine in the USA, it’s important to consider alternative online degrees and career pathways in healthcare. Many students look for flexible programs to accelerate their careers or specialize in fields with high demand.

For those aiming for advanced practice roles, the easiest dnp program reddit discussions can shed light on fast, accessible Doctor of Nursing Practice programs. If you want to start your career quickly, you might consider enrolling in a fastest lpn program—these options can shorten the timeline to becoming a Licensed Practical Nurse.

Mental health is another area with growing opportunities. Many choose online psych np programs to become Psychiatric Mental Health Nurse Practitioners, providing specialized care with greater flexibility. If you’re interested in the business side of healthcare, pursuing an online health management degree can prepare you for leadership roles in hospitals or clinics.

These pathways can offer shorter completion times, cost savings, or advanced specialization. Exploring these alternatives can help you carve out a fulfilling and impactful career in the healthcare sector.

Best Scientists Citing Matthias Schwab

Trending Scientists

Recently Published Articles